You just read:

Sotagliflozin Data from Pivotal inTandem1 and inTandem2 Studies in Patients with Type 1 Diabetes Presented at ADA 2017

News provided by

Lexicon Pharmaceuticals, Inc.

Jun 10, 2017, 13:01 ET